Novo Nordisk A/S’s Net Profit Margin at a glance
Novo Nordisk A/S reports net profit margin of 34.8% for Dec 2024. The prior period recorded 36% (Dec 2023). Year over year the metric moved −1.3 pts (−3.5%). The rolling three-period average stands at 34.1%. Data last refreshed Dec 7, 2025, 2:49 AM.
Latest reading
34.8% · Dec 2024
YoY movement
−1.3 pts (−3.5%)
Rolling average
34.1%
Current Net Profit Margin
34.8%
−1.3 pts
−3.5%
Rolling average
34.1%
Latest Value
34.8%
Dec 2024
YoY Change
−1.3 pts
Absolute
YoY Change %
−3.5%
Rate of change
3-Period Avg
34.1%
Smoothed
Narrative signal
Novo Nordisk A/S’s net profit margin stands at 34.8% for Dec 2024. Year-over-year, the metric shifted by −1.3 pts, translating into a −3.5% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How net profit margin shapes Novo Nordisk A/S's story
As of Dec 2024, Novo Nordisk A/S reports net profit margin of 34.8%. Assess earnings efficiency, margin resiliency, and profitability drivers using annual historical margins.
Monitoring margin quality
Expanding margins signal improved cost control or pricing power. Contracting margins can point to rising input costs, pricing pressure, or product mix shifts.
Pair margin with growth metrics
Combine margin trends with revenue growth to understand whether the company is scaling efficiently or sacrificing profitability for expansion.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Novo Nordisk A/S (NVO) FAQs
Answers tailored to Novo Nordisk A/S’s net profit margin profile using the latest Financial Modeling Prep data.
What is Novo Nordisk A/S's current net profit margin?
As of Dec 2024, Novo Nordisk A/S reports net profit margin of 34.8%. This reading reflects the latest filings and price data for NVO.
How is Novo Nordisk A/S's net profit margin trending year over year?
Year-over-year, the figure shifts by −1.3 pts (−3.5%). Pair this context with revenue growth and free cash flow signals to gauge momentum for NVO.
Why does net profit margin matter for Novo Nordisk A/S?
Net profit margin measures how much of each dollar of revenue turns into net income after all expenses. For Novo Nordisk A/S, operating within Healthcare — Drug Manufacturers - General, tracking this metric helps benchmark management's execution against close competitors.
Is Novo Nordisk A/S's net profit margin above its recent average?
Novo Nordisk A/S's rolling three-period average sits at 34.1%. Comparing the latest reading of 34.8% to that baseline highlights whether momentum is building or fading for NVO.
How frequently is Novo Nordisk A/S's net profit margin refreshed?
Data for NVO was last refreshed on Dec 7, 2025, 2:49 AM and updates automatically every 24 hours, keeping your valuation inputs current.
